![]() |
市场调查报告书
商品编码
1959988
医用皮肤黏合剂市场-全球产业规模、份额、趋势、机会、预测:按类型、产品、最终用户、地区和竞争格局划分,2021-2031年Medical Stick-to-Skin Adhesives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End User, By Region & Competition, 2021-2031F |
||||||
全球医用皮肤黏合剂市场预计将从 2025 年的 28.3 亿美元成长到 2031 年的 44.5 亿美元,复合年增长率为 7.84%。
这些黏合剂是专门设计的生物相容性黏合剂,用于将穿戴式感测器、伤口敷料、医疗设备和其他组件牢固、长期地固定在皮肤上。市场成长的主要驱动力是心血管疾病和糖尿病等慢性疾病的日益普遍,这些疾病需要频繁的创伤护理和持续监测。全球人口老化也进一步强化了这一成长趋势,因为老化需要持续的医疗支援。根据国际糖尿病联盟的数据,到2024年,全球将有约5.89亿成年人患有糖尿病,凸显了依赖黏合剂的解决方案(例如溃疡敷料和血糖监测仪)的重要性。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 28.3亿美元 |
| 市场规模:2031年 | 44.5亿美元 |
| 复合年增长率:2026-2031年 | 7.84% |
| 成长最快的细分市场 | 丙烯酸纤维 |
| 最大的市场 | 北美洲 |
然而,阻碍市场扩张的一大挑战是医用黏合剂相关皮肤损伤(MARSI)的发生。製造商难以平衡强力黏合与温和非侵入性移除的要求,尤其是在皮肤脆弱的老年患者。这构成了一项技术障碍,可能会限制产品在敏感临床应用中的使用。
穿戴式医疗设备和远端患者监护的日益普及正在从根本上改变全球医用皮肤黏合剂市场,製造商优先研发生物相容性配方,以确保感测器能够长时间牢固固定。这一趋势在持续血糖监测 (CGM) 系统的快速发展中尤其明显,这类系统需要使用不易脱落且能在各种环境条件下保持皮肤完整性的黏合剂。主要设备製造商的财务表现也反映了这些依赖黏合剂技术的激增。根据 Dexcom 于 2025 年 10 月发布的 2025 年第三季财报,其全球营收年增 22% 至 12.09 亿美元,凸显了黏合剂贴片对于满足不断增长的用户群的重要性。此外,对贴片式给药系统的广泛需求也推动了这一趋势。根据 Inslet 于 2025 年 11 月发布的 2025 年第三季财报,其依赖黏合剂的无管胰岛素帮浦技术带来的总收入达到 7.063 亿美元。
同时,先进创伤护理和外科敷料市场的成长成为第二个驱动因素,市场对既能牢固固定又能无痛移除的黏合剂的需求日益增长,尤其适用于脆弱的皮肤。随着慢性疾病和人口老化推动了对先进伤口管理的需求,泡沫敷料和皮肤替代物的消费量正在加速增长,黏合剂的创新也正朝着保湿和低过敏性解决方案的方向发展。这一细分市场的扩张也反映在近期的行业趋势。根据史密斯医疗(Smith+Nephew)于2025年11月发布的《2025年第三季交易报告》,其先进伤口护理业务部门实现了6.0%的收入增长,这反映出临床上对高性能粘合敷料在有效促进患者康復方面的持续依赖。
全球医用皮肤黏合剂市场扩张面临的主要挑战是医用黏合剂相关皮肤损伤(MARSI)的高发生率。製造商面临一个复杂的技术难题:他们必须开发出既能为大型装置提供牢固持久黏合,又能确保非侵入性移除的产品。要实现这一平衡并非易事,因为强力黏合剂在移除时往往会导致皮肤完整性受损的患者出现皮肤剥落或撕裂。因此,医疗专业人员通常不愿意为脆弱的病患小组采用基于黏合剂的监测解决方案,这在对皮肤安全性要求极高的临床环境中构成了市场渗透的重大障碍。
由于易受黏合剂相关皮肤损伤影响的人群正在迅速增长,这项技术限制构成了一个严重的障碍。无法保证皮肤安全阻碍了市场充分利用老年护理产品日益增长的需求。根据人口参考局预测,到2024年,全球10%的人口将达到或超过65岁。鑑于大量患者天生皮肤脆弱,医用黏合剂相关皮肤损伤(MARSI)的风险显然限制了市场规模。製造商正努力为这一不断增长的高风险族群开发安全的黏合剂。
生物降解和生物基材料的开发正在迅速改变医用皮肤黏合剂的化学成分。这主要是由于该行业迫切需要减少对石油的依赖以及范围3排放。製造商正积极用可堆肥和可再生资源衍生的替代品取代传统的丙烯酸和合成橡胶配方,以最大限度地减少对环境的影响,同时保持临床等级的黏性。这种转变在技术上极具挑战性,因为生物聚合物必须在患者使用过程中能够耐受水分和细菌滋生,并在处置后高效分解。由于近期材料创新,这些永续方案的商业性可行性正变得越来越清晰。根据2025年11月《黏合剂杂誌》(Adhesives Magazine)报导「压敏黏着剂下一代高科技製造」的文章,汉高公司开发了生物基含量高达70%的「TECHNOMELT DM ECO」配方,在不影响黏合剂耐久性的前提下,为降低黏合剂产品的碳棒树立了新的标竿。
智慧型感测器整合黏合剂的出现,正将被动固定剂转变为能够即时进行伤口管理的诊断工具。传统的OK绷黏合剂只能将伤口固定到位,而这些先进的系统则融合了生物电子技术和刺激应答型高分子,能够检测感染标记(例如pH值变化),并自主触发治疗性介入。这种整合创造了封闭回路型癒合环境,其中黏合剂层本身不再只是机械固定装置,而是直接参与加速组织恢復。检验这些系统有效性的研究凸显了它们革新慢性创伤护理的潜力。根据2025年9月发表在ScienceDaily上的一篇题为「人工智慧驱动的智慧绷带创伤治疗25%」的报告,新型封闭回路型黏合剂装置的临床前试验表明,与标准治疗相比,癒合速度提高了约25%,这表明能够积极参与生理癒合过程的黏合剂具有巨大的市场潜力。
The Global Medical Stick-to-Skin Adhesives Market is projected to expand from a valuation of USD 2.83 Billion in 2025 to USD 4.45 Billion by 2031, reflecting a CAGR of 7.84%. These adhesives function as specialized, biocompatible bonding agents designed to securely attach wearable sensors, wound dressings, and medical devices to the epidermis for prolonged durations. The market's growth is primarily fueled by the increasing incidence of chronic conditions, such as cardiovascular diseases and diabetes, which necessitate frequent wound care and continuous monitoring. This upward trajectory is further bolstered by an aging global demographic that requires sustained medical assistance. Data from the International Diabetes Federation indicates that approximately 589 million adults worldwide were living with diabetes in 2024, underscoring the critical need for adhesive-dependent solutions like ulcer dressings and glucose monitors.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.83 Billion |
| Market Size 2031 | USD 4.45 Billion |
| CAGR 2026-2031 | 7.84% |
| Fastest Growing Segment | Acrylic-Based |
| Largest Market | North America |
However, a significant challenge impeding market expansion is the prevalence of Medical Adhesive-Related Skin Injury (MARSI). Manufacturers struggle to balance the need for robust adhesion with the requirement for gentle, trauma-free removal, particularly for elderly patients with fragile skin, creating a technical barrier that can limit product adoption in sensitive clinical applications.
Market Driver
Rising adoption of wearable medical devices and remote patient monitoring is fundamentally reshaping the Global Medical Stick-to-Skin Adhesives Market, as manufacturers prioritize biocompatible formulations capable of securing sensors for extended durations. This trend is exemplified by the rapid expansion of continuous glucose monitoring (CGM) systems, which require adhesives that maintain skin integrity under varying environmental conditions without detaching. The surge in utilization of these adhesive-reliant technologies is evident in the financial performance of major device manufacturers. According to Dexcom, October 2025, in the 'Third Quarter 2025 Financial Results', worldwide revenue grew 22% year-over-year to $1.209 billion, underscoring the critical volume of adhesive patches required to support this expanding user base. Furthermore, the broader demand for patch-based delivery systems reinforces this trajectory; according to Insulet, November 2025, in the 'Third Quarter 2025 Results', total revenue reached $706.3 million, driven by the adoption of their adhesive-dependent tubeless insulin pump technology.
Concurrently, growth in the advanced wound care and surgical dressings market acts as a secondary powerhouse, necessitating adhesives that balance strong fixation with atraumatic removal for fragile skin. As chronic conditions and an aging demographic drive the need for sophisticated wound management, the consumption of foam dressings and skin substitutes has accelerated, pushing adhesive innovation toward moisture-managing and hypoallergenic solutions. This segment's expansion is quantitatively visible in recent industry updates. According to Smith+Nephew, November 2025, in the 'Third Quarter 2025 Trading Report', the Advanced Wound Management business unit delivered revenue growth of 6.0%, reflecting the sustained clinical reliance on high-performance adhesive dressings for effective patient recovery.
Market Challenge
The primary challenge impeding the expansion of the Global Medical Stick-to-Skin Adhesives Market is the prevalence of Medical Adhesive-Related Skin Injury (MARSI). Manufacturers face a complex technical contradiction where they must engineer products that offer robust, long-term adhesion for heavy wearable devices while simultaneously ensuring atraumatic removal. This balance is difficult to achieve for patients with compromised skin integrity, as strong bonding agents often cause skin stripping or tearing upon detachment. Consequently, healthcare providers frequently hesitate to adopt adhesive-based monitoring solutions for vulnerable patient groups, creating a significant barrier to market penetration in clinical settings that require superior skin safety.
This technical limitation acts as a severe constraint because the demographic most susceptible to adhesive injury is expanding rapidly. The inability to guarantee skin safety prevents the market from fully capitalizing on the growing demand for geriatric care products. According to the Population Reference Bureau, in 2024, 10% of the global population was aged 65 and older. This substantial volume of patients with naturally fragile skin highlights how the risk of MARSI directly limits the addressable market, as manufacturers struggle to produce adhesives that are safe for this widening high-risk category.
Market Trends
The development of biodegradable and bio-based materials is rapidly altering the chemical composition of medical stick-to-skin adhesives, driven by the industry's urgent need to reduce petroleum reliance and Scope 3 emissions. Manufacturers are actively replacing traditional acrylic and synthetic rubber formulations with compostable, renewably sourced alternatives that maintain clinical-grade tackiness while minimizing environmental impact. This shift is technically demanding, as bio-polymers must resist moisture and bacterial growth during patient use, yet break down efficiently post-disposal. The commercial viability of these sustainable options is increasingly evident in recent material innovations. According to Adhesives Magazine, November 2025, in the article 'Pressure-Sensitive Adhesives Enable the Next Wave of High-Tech Manufacturing', Henkel introduced the TECHNOMELT DM ECO formulation which delivers 70% bio-based content, establishing a new benchmark for reducing the carbon footprint of adhesive products without compromising bonding durability.
The emergence of smart and sensor-integrated adhesives is transforming passive fixing agents into active diagnostic tools capable of real-time wound management. Unlike standard adhesives that simply secure a dressing, these advanced systems incorporate bioelectronics and stimuli-responsive polymers to detect infection markers, such as pH changes, and autonomously trigger therapeutic interventions. This integration creates closed-loop healing environments where the adhesive layer itself plays a direct role in accelerating tissue recovery rather than serving solely as a mechanical fastener. Research validating the efficacy of these systems highlights their potential to revolutionize chronic wound care. According to ScienceDaily, September 2025, in the report 'AI-powered smart bandage heals wounds 25% faster', preclinical tests of a new closed-loop adhesive device demonstrated a healing trajectory approximately 25% faster than standard care, validating the market potential for adhesives that actively participate in the physiological healing process.
Report Scope
In this report, the Global Medical Stick-to-Skin Adhesives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Medical Stick-to-Skin Adhesives Market.
Global Medical Stick-to-Skin Adhesives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: